SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tony nikou who wrote (972)7/10/1998 12:45:00 PM
From: Tulvio Durand   of 1055
 
Tony, I am holding and have added recently to my shares as I am anticipating price recovery and am expecting reasonably good near term performance. I would suggest you look at the last 50 or so posts on this board and the co's 10K's, etc., to gauge the competition. It seems to me that THRX has a monopoly, at present, on Pd 103 seeds -- a product for which demand outstrips supply. THRX is adding capacity to meet demand and its earnings should grow substantially in the near term (through 1999). But the situation could change rapidly and needs to be monitored vigilantly. NASI's success/failure in making cheaper Pd 103 seeds, which should be known in September, is a critical determinant in THRX's continued success. G/L. Tulvio
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News